GES

Gemoscan Canada, Inc. ("Gemoscan" or the "Company") - (TSX VENTURE:GES)
(MUN:1GE) is pleased to announce the appointment of Felice Fleisher as Senior
Vice President Sales and Marketing. Ms. Fleisher reports to President and CEO,
Brian Kalish.


Ms. Fleisher brings more than 20 years experience in both the U.S. and Canadian
business and corporate environments with general management and hands on skills
in all areas of business development including sales, marketing, analytics,
planning, operations, supply chain, IT and systems oversight, ERP/transition
planning, budgets, forecasting and government relations. 


From 1990 - 2009, Ms. Fleisher held senior management positions at Paramount
Home Entertainment Canada, including Senior Vice President and General Manager
(2004-2009), Senior Vice President (1998-2003), Vice President Sales (1994-1997)
and Executive Director Sales and Operations (1990-1993). During her tenure, Ms.
Fleisher established the Canadian office from start-up quickly developing
Paramount Home Entertainment to one of Canada's top grossing and most respected
home entertainment studios. From 1986 to 1990, Ms. Fleisher held management
positions at Paramount Pictures Corporation and Paramount Home Video including
Director of Distribution Marketing and Regional Sales Manager.


Brian Kalish, President and CEO commented, "We are delighted to welcome Felice
to the Gemoscan team and look forward to her contributions as we take the
Company to the next level in building the HEMOCODE brand."


ABOUT GEMOSCAN CANADA, INC.

Founded in 2003, Gemoscan Canada, Inc. owns and markets the HEMOCODE(TM) Food
Intolerance System, a personalized naturopathic nutritional program that
promotes wellbeing. HEMOCODE(TM) uses patented technology and services to
provide consultation and recommendations to simplify the management of food
sensitivities. Gemoscan Canada, Inc. trades its shares on the Toronto Venture
Exchange (TSX-V) under the symbol GES.


Forward-Looking Information 

This news release contains certain "forward-looking information". All
statements, other than statements of historical fact that address activities,
events or developments that Gemoscan believes, expects or anticipates will or
may occur in the future. These forward-looking statements reflect the current
expectations or beliefs of Gemoscan based on information currently available to
Gemoscan. Forward-looking statements are subject to a number of significant
risks and uncertainties and other factors that may cause the actual results of
Gemoscan to differ materially from those discussed in the forward-looking
statements, and even if such actual results are realized or substantially
realized, there can be no assurance that they will have the expected
consequences to, or effects on Gemoscan. Any forward-looking statement speaks
only as of the date on which it is made and, except as may be required by
applicable securities laws, Gemoscan disclaims any intent or obligation to
update any forward-looking statement, whether as a result of new information,
future events or results or otherwise. Although Gemoscan believes that the
assumptions inherent in the forward-looking statements are reasonable,
forward-looking statements are not guarantees of future performance and
accordingly undue reliance should not be put on such statements due to the
inherent uncertainty therein.

Gemoscan Canada, Inc. (TSXV:GES)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Gemoscan Canada, Inc. (TSXV:GES)
Historical Stock Chart
Von Jun 2023 bis Jun 2024